These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2300682)
61. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. Titeler M; Lyon RA; Davis KH; Glennon RA Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239 [TBL] [Abstract][Full Text] [Related]
62. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat. Chaouloff F; Courvoisier H; Moisan MP; Mormède P Psychopharmacology (Berl); 1999 Jan; 141(3):326-31. PubMed ID: 10027515 [TBL] [Abstract][Full Text] [Related]
63. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872 [TBL] [Abstract][Full Text] [Related]
64. The role of spinal cord 5-HT1A and 5-HT1B receptors in the modulation of a spinal nociceptive reflex. Eide PK; Joly NM; Hole K Brain Res; 1990 Dec; 536(1-2):195-200. PubMed ID: 2150769 [TBL] [Abstract][Full Text] [Related]
65. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Schlicker E; Werner U; Hamon M; Gozlan H; Nickel B; Szelenyi I; Göthert M Br J Pharmacol; 1992 Mar; 105(3):732-8. PubMed ID: 1628159 [TBL] [Abstract][Full Text] [Related]
66. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat. Bervoets K; Millan MJ; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818 [TBL] [Abstract][Full Text] [Related]
67. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405 [TBL] [Abstract][Full Text] [Related]
68. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice. Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529 [TBL] [Abstract][Full Text] [Related]
69. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes. Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345 [TBL] [Abstract][Full Text] [Related]
70. Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Kennett GA; Curzon G Br J Pharmacol; 1991 Aug; 103(4):2016-20. PubMed ID: 1912990 [TBL] [Abstract][Full Text] [Related]
71. Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation. Schechter MD Pharmacol Biochem Behav; 1988 Sep; 31(1):53-7. PubMed ID: 3252260 [TBL] [Abstract][Full Text] [Related]
72. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575 [TBL] [Abstract][Full Text] [Related]
73. Neurochemical effects of 5-HT1 receptor ligands in pigeons. Gleeson S; Weissman BA; Seggel MR; Barrett JE Eur J Pharmacol; 1992 Dec; 229(2-3):109-15. PubMed ID: 1283373 [TBL] [Abstract][Full Text] [Related]
74. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Njung'e K; Handley SL Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200 [TBL] [Abstract][Full Text] [Related]
75. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze. Jones N; Duxon MS; King SM Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085 [TBL] [Abstract][Full Text] [Related]
76. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Schoeffter P; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889 [TBL] [Abstract][Full Text] [Related]
77. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. Barrett JE; Gleeson S Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937 [TBL] [Abstract][Full Text] [Related]
78. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Harrison AA; Parsons LH; Koob GF; Markou A Psychopharmacology (Berl); 1999 Jan; 141(3):242-50. PubMed ID: 10027505 [TBL] [Abstract][Full Text] [Related]
79. Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice. Takeshita N; Yamaguchi I Br J Pharmacol; 1995 Dec; 116(8):3133-8. PubMed ID: 8719787 [TBL] [Abstract][Full Text] [Related]
80. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat. Chaouloff F; Laude D; Baudrie V Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]